Standard E Dengue Igg Capture Elisa

Product Details:

Number of Reactions(Preps)/Kit : 50
Brand : SD
ICMR Approved : Yes
Result Time (Rapid Kits) : 15 min
Sample Type : Oral & Nasal Swab
STANDARD E Dengue IgM ELISA analyzes IgM antibodies specific to Dengue virus in serum and plasma using enzyme linked immunosorbent assay.

Product Details:

Number of Reactions(Preps)/Kit : 50T
Brand : SD Biosensor
ICMR Approved : Yes
Result Time (Rapid Kits) : 15 min
Sample Type : Blood
Country of Origin : Made in India
STANDARD E Dengue NS1 Ag ELISA analyzes Dengue NS1 antigens in serum and plasma using enzyme linked immunosorbent assay.

Simple and easy to use: All necessary reagents included in the kit
Highest accuracy with all dengue serotypes(DEN1,2,3, and 4)
Able to detect antigens in samples with high sensitivity and specificity
Performance
Sensitivity : 91.4% (181/198) / Specificity : 98.2% (221/225)

Product Details:

Number of Reactions(Preps)/Kit : 96 wells
Brand : Abbott
Usage/Application : Hospital
Sample Material : Serum
CAT No : 11EK10
The Panbio Dengue IgM Capture ELISA is used to detect IgM antibodies to dengue antigen in serum as an aid to clinical laboratory diagnosis of patients with clinical symptoms consistent with dengue fever. The Panbio. Dengue IgM Capture ELISA should be used in conjunction with other dengue serology.

Product Details:

Number of Reactions(Preps)/Kit : 96wells
Brand : Abbott
Cat. No : 01PE10
The Panbio Dengue IgG Capture ELISA is used to detect elevated IgG antibodies to dengue virus (serotypes 1-4) in patients with secondary infection. This test is intended as an aid in the clinical laboratory diagnosis.

Product Details:

Brand : Abbott
Package type : Microplate
Pack size : 96wells/Kit
Specimen : Serum
Description : Dengue IgM Capture ELISA
Cat.No. : 11EK20
Bioline DENGUE IgM CAPTURE ELISA

In primary infection with the dengue virus, IgM antibody becomes detectable about five days after disease onset, when circulating virus declines in the blood. IgM level rises quickly to peak at about 2 weeks and declines to undetectable levels after 2-3 months In secondary infections, IgM response is typically at a lower level compared to that in a primary infection. Early diagnosis of dengue infection (especially in primary dengue infection) High accuracy with all dengue serotypes (DEN1,2,3, and 4) Simple and easy to use: All necessary reagents included in the kit Shelf life and storage temperature: 18 months from the date of manufacturing at 2-8 C Included in the WHO Bulk Procurement Scheme Performance: Sensitivity 96.4 %, Specificity 98.9 % (vs. HAI test).

Product Details:

Number of Reactions(Preps)/Kit : 96 Wells
Brand : CTK BioTech
Sample : serum or plasma
Storage : 2-8 c
Cat No : AE0311
INTENDED USE :

The Dengue IgG ELISA is a solid-phase enzyme-linked immunosorbent assay for the qualitative detection of elevated anti-dengue viruses (DEN1, 2, 3, 4) IgG in human serum or plasma. It is intended for professional use only as an aid in the diagnosis of active infection with dengue viruses, including secondary infection.

TEST PRINCIPLE:
The Dengue IgG ELISA Kit is a solid-phase enzyme-linked immunosorbent assay based on the principle of the capture immunoassay methodology for the detection of IgG anti-dengue virus in human serum or plasma. The Dengue IgG ELISA Kit is composed of two key components: 1) Solid microwells pre-coated with mouse monoclonal anti-human IgG antibody. 2) Conjugate composed of biotinylated dengue antigens and avidin HRP-conjugates. During the assay, the test specimen is first incubated in the coated microwell. IgG antidengue, if present in the specimen, binds to the anti-human IgG antibodies coated on the microwell surface, and any unbound specimen is then removed by a wash step. During a second incubation with Biotinylated dengue antigens, the IgG anti-dengue absorbed on the surface of microwell binds with dengue antigen, forming a complex. Unbound antigens are then removed by washing. After addition of Streptavidin HRP conjugate, it binds with biotinylated antigen and forming complex with HRP conjugate. After addition of the TMB substrate, the presence of the conjugate complex is shown by development of a blue color resulting from a reaction between the enzyme and substrate. This reaction is then quenched by addition of the Stop Solution, and the absorbance value for each microwell is determined using a spectrophotometer at 450/620-690 nm.

Accuracy of Detection :

A total of 262 patient specimens were collected from susceptible subjects and tested by Dengue IgG ELISA Kit and by a commercial leading brand EIA.

Relative Sensitivity: 95.2% (95% Confidence Interval = 83.8 - 99.4%)
Relative Specificity: 96.8% (95% Confidence Interval = 93.6 - 98.7%)
Overall agreement: 96.6% (95% Confidence Interval = 93.6 - 98.4%)

Product Details:
Number of Reactions(Preps)/Kit :20T
Brand : SD Biosensor
ICMR Approved : Yes
Result Time (Rapid Kits) : 15min
CAT No : RK012-20
One step, rapid, immunochromatographic test for the detection of Dengue IgMlIgG antibodies to four senatypes of dengue virus (DEN-I, DEN-2. DEN-3 and DEN-4) in human serum, plasma or whole blood.
Kit Contents:
Standard Q Dengue IgM IgG cassette x 20
Specimen transfer device 10ml x 20
Butter bottle 4ml x 01
Instructions for use x 1
STANDARD Q Dengue IgM/IgG qualitatively analyzes IgM and IgG antibodies specific to Dengue virus in serum, plasma and whole blood using immunochromatography. By detecting IgM and IgG specific to Dengue virus, the primary and secondary Dengue virus infections can be discriminated, and the screening test result can be obtained within 15 minutes with its high sensitivity and specificity.

Advantage:
Differential detection of IgG and IgM antibodies
Easy to use, Easy to read and interpret
Room temperature storage
Able to read positive/negative infections fast and accurately with a little amount of sample (10 �µl)

Vannin Healthcare offers several effective COVID-19 tests:
SGTi-flex COVID-19 IgM/IgG (25 tests per kit)
STANDARD Q COVID-19 IgM/IgG Duo Test (40 tests per kit)
Anti-SARS-CoV-2 Rapid Test (50 tests per kit)
General Features
Can detect and differentiate between IgM and IgG antibodies
Convenient: no additional equipment necessary
Extremely fast: results in 10-15 minutes
Point-of-care testing
Allow rapid decision-making in high-stakes situations
Why our tests
Certified: CE-IVD marked, FDA-cleared, ISO 13485, Korea GMP-certified
Reliable: high clinical specificity and selectivity
Easy to interpret
Can detect antibodies even in asymptomatic patients

Vannin Healthcare Global offers various diagnostic and serology tests for identifying the presence of Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV-2). SARS-CoV-2 is the virus that causes COVID-19 which means that its presence could indicate that a person has been infected.

There are two types of tests currently used to determine the presence of the virus:

Molecular diagnostic tests or viral tests (Swab tests)
Antibody serology tests (Blood tests)
Vannin Healthcare Global's Serology Tests

To find out whether antibodies are present in an obtained sample (whole blood, plasma, or serum), serology tests are used. The presence of antibodies could indicate a past infection. And depending on the type of the immunoglobulins present, it could also determine the approximate time when the infection occurred.

After fighting a coronavirus, our bodies are likely to produce two classes of antibodies: IgM and IgG. In the case of SARS-CoV-2, both IgM and IgG are most likely to occur simultaneously within two to three weeks after a person's been infected. For a firmer diagnosis, Vannin Healthcare Global offers serology tests that check for both IgM and IgG antibodies.

Can detect and differentiate between IgM and IgG antibodies

Differentiating between the antibodies is crucial when it comes to providing proper medical advice to your patients. The appearance of IgM antibodies is the initial response of the organism fighting to suppress the virus. These antibodies could indicate that the patient is still infectious, and advising patients to self-isolate is the appropriate course of action. IgG antibodies can be detected in the blood sample usually within7-10 days after the onset of infection. If a patient has IgG antibodies, and no IgM antibodies, they have developed a temporary immunity to COVID-19.

No additional equipment necessary

The test design makes it a perfect choice for remote areas without access to fully-equipped laboratories. Simply obtain a blood sample from a patient, and add 10�µl into the appropriate place on the testing cassette along with three drops (90µl) of the buffer. The results will appear in 10-15 minutes.

INTENDED USE

THE ONE STEP ANTI-DENGUE (IGM & IGG) TRI-LINE TEST IS A COLLOIDAL GOLD ENHANCED, RAPID IMMUNOCHROMATOGRAPHIC ASSAY FOR THE QUALITATIVE DETECTION OF ANTIBODIES (IGM & IGG) TO DENGUE VIRUS (DV) IN HUMAN WHOLE BLOOD, SERUM OR PLASMA. THIS TEST IS A SCREENING TEST, AND ALL POSITIVES MUST BE CONFIRMED USING AN ALTERNATE TEST SUCH AS WESTERN BLOT. THE TEST IS INTENDED FOR HEALTHCARE PROFESSIONAL USE ONLY.


25PCS/BOX